 |
|
|
| |
Mechanism for Hypertriglyceridemia and Effect of Fibrate
Coadministration During Acetyl-CoA Carboxylase Inhibitor Treatment
|
| |
| |
Reported by Jules Levin
EASL 2018 April 11-15 Paris France
Leigh Goedeke1*, Jamie Bates2*, Daniel F. Vatner1, Rachel J. Perry1 , Matthew W. Ellis3, Ting Wang2, G. Mani Subramanian2, Robert P. Meyers2, Adrian S. Ray2, Gerald I. Shulman1,3,4
1Department of Internal Medicine, Yale University; 2Gilead Sciences Inc., Foster City CA, 94404, 3Department of Cellular & Molecular Physiology; 4Howard Hughes Medical Institute, Yale University School of Medicine, New Haven CT 06520
*Contributed equally to work
|
| |
|
|
|
|
|
